Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback